Advanced Enzyme Technologies Ltd Share Price – NSE /  BSE

Pharmaceuticals, Small Cap

Advanced Enzyme Techs. announced that the Board of Directors of the Company at its meeting held on 9 May 2026, inter alia, have recommended the final dividend of Rs 1.35 per equity Share (i.e. 67.5%) , subject to the approval of the shareholders.

Net profit of Advanced Enzyme Technologies rose 62.24% to Rs 42.96 crore in the quarter ended March 2026 as against Rs 26.48 crore during the previous quarter ended March 2025. Sales rose 21.65% to Rs 203.37 crore in the quarter ended March 2026 as against Rs 167.18 crore during the previous quarter ended March 2025.

For the full year,net profit rose 28.68% to Rs 168.72 crore in the year ended March 2026 as against Rs 131.12 crore during the previous year ended March 2025. Sales rose 17.09% to Rs 745.76 crore in the year ended March 2026 as against Rs 636.91 crore during the previous year ended March 2025.

Powered by Capital Market - Live News

Advanced Enzyme Techs. will hold a meeting of the Board of Directors of the Company on 9 May 2026.

Advanced Enzyme Technologies announced that ICRA has rated the company's debt facilities of Rs 100 crore at ICRA AA-; Stable; ICRA A1+.

Powered by Capital Market - Live News